Equities researchers at StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Stock Performance
Shares of Global Cord Blood stock opened at $1.75 on Friday. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The company has a market cap of $212.71 million, a P/E ratio of 2.73 and a beta of 0.16. The stock has a 50-day moving average price of $1.52 and a 200 day moving average price of $1.35.
Global Cord Blood Company Profile
Further Reading
- Five stocks we like better than Global Cord Blood
- What is Put Option Volume?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Insider Selling Explained: Can it Inform Your Investing Choices?
- MarketBeat Week in Review – 9/23 – 9/27
- Breakout Stocks: What They Are and How to Identify Them
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.